Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada; Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden.
Parkinsonism Relat Disord. 2018 Sep;54:99-102. doi: 10.1016/j.parkreldis.2018.04.010. Epub 2018 Apr 4.
Studies estimate that >80% of patients with idiopathic REM sleep behavior disorder (iRBD) eventually develop parkinsonism or dementia. However, a small group remains disease-free for long periods, raising the question of whether they truly have prodromal disease.
We selected subjects with iRBD who were diagnosed at least 10 years previously, and were still disease free (longstanding iRBD) (n = 11). We compared them to 'early converters' (n = 27) defined as those who phenoconverted to parkinsonism or dementia within 4 years after diagnosis, and to age- and sex-matched healthy controls (n = 68). We compared the frequency and progression of numerous markers of prodromal synucleinopathy between groups, and assessed likelihood of meeting prodromal Parkinson's disease criteria.
After at least 10 years follow-up, almost all longstanding iRBD subjects showed multiple features of neurodegeneration, and 9/11 met criteria for prodromal PD. Evolution of markers was slower than early-converters, with an annual increase in prodromal PD probability of 3.9 ± 3.2% in longstanding iRBD compared to 12.4 ± 7.8% for early-convertors (p-value = 0.002). However, subjects with longstanding iRBD at their last visit had similar prodromal measures as the baseline evaluation of the early-convertors, with similarly-abnormal UPDRS scores, quantitative motor tests, cognition and autonomic symptoms and signs.
Although phenoconversion rates can differ dramatically between patients, almost all individuals with iRBD in our cohort appear to have underlying neurodegeneration.
研究估计,超过 80%的特发性 REM 睡眠行为障碍(iRBD)患者最终会发展为帕金森病或痴呆症。然而,一小部分患者在很长一段时间内保持无病状态,这就提出了一个问题,即他们是否真的有前驱疾病。
我们选择了至少在 10 年前被诊断为 iRBD 且仍未患病的患者(长期 iRBD)(n=11)。我们将他们与“早期转化者”(n=27)进行比较,早期转化者在诊断后 4 年内出现帕金森病或痴呆的表型转化,同时与年龄和性别匹配的健康对照组(n=68)进行比较。我们比较了各组中前驱性突触核蛋白病的多个标志物的频率和进展,并评估了符合前驱性帕金森病标准的可能性。
在至少 10 年的随访后,几乎所有长期 iRBD 患者都出现了多种神经退行性变的特征,9/11 例符合前驱性 PD 的标准。标志物的演变速度比早期转化者慢,长期 iRBD 患者的前驱性 PD 概率每年增加 3.9%±3.2%,而早期转化者为 12.4%±7.8%(p 值=0.002)。然而,在最后一次就诊时患有长期 iRBD 的患者的前驱性测量值与早期转化者的基线评估相似,他们的 UPDRS 评分、定量运动测试、认知和自主症状和体征同样异常。
尽管患者之间的表型转化率可能存在显著差异,但我们队列中的几乎所有 iRBD 患者似乎都存在潜在的神经退行性变。